Top1000 Scholar

Scholarly Index

Antoîne Italiano

Institut Bergonié; 43,672 total citations; 1,043 total publications; best world rank #2

Institut Bergonié

43,672Total citations
1,043Total publications
97H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Medical and Health Sciences2021-2025255FR 999.95
Pulmonary and Respiratory MedicineLifetime138FR 899.83
OncologyLifetime274FR 1699.55
Pathology and Forensic MedicineLifetime891FR 2995.61
RheumatologyLifetime881FR 3394.92
GastroenterologyLifetime392FR 1193.45
Pulmonary and Respiratory Medicine2021-202536FR 799.85
Oncology2021-202552FR 599.72
Molecular Biology2021-2025910FR 1894.90
Cancer Research2021-2025136FR 493.02
Immunology2021-2025416FR 1288.30
Gastroenterology2021-2025152FR 586.23
Radiology, Nuclear Medicine and Imaging2021-2025666FR 1285.13
Sarcoma Diagnosis and TreatmentLifetime23FR 299.83
Cardiac tumors and thrombiLifetime20FR 299.75
Vascular Tumors and AngiosarcomasLifetime19FR 299.64
Cancer Immunotherapy and BiomarkersLifetime149FR 1599.61
Gastrointestinal Tumor Research and TreatmentLifetime136FR 999.07
Peptidase Inhibition and AnalysisLifetime382FR 1498.53
Bone Tumor Diagnosis and TreatmentsLifetime182FR 598.63
Lymphoma Diagnosis and TreatmentLifetime480FR 3298.77
Lung Cancer Treatments and MutationsLifetime573FR 2798.76
Chromatin Remodeling and CancerLifetime67FR 397.89
Tumors and Oncological CasesLifetime182FR 998.17
Colorectal Cancer Treatments and StudiesLifetime492FR 3798.52
CAR-T cell therapy researchLifetime626FR 3298.28
Cancer Genomics and DiagnosticsLifetime984FR 4898.29
Cancer Diagnosis and TreatmentLifetime614FR 3197.06
Neurofibromatosis and Schwannoma CasesLifetime239FR 1597.33
Soft tissue tumors and treatmentLifetime47FR 597.04
Advanced Breast Cancer TherapiesLifetime380FR 2296.95
Protein Degradation and InhibitorsLifetime640FR 3295.64
Soft tissue tumor case studiesLifetime370FR 2095.24
PARP inhibition in cancer therapyLifetime604FR 2993.68
Musculoskeletal synovial abnormalities and treatmentsLifetime489FR 1394.52
Sarcoma Diagnosis and Treatment2021-20252FR 299.90
Cancer Immunotherapy and Biomarkers2021-202556FR 699.77
Cancer Genomics and Diagnostics2021-2025122FR 698.99
Peptidase Inhibition and Analysis2021-202573FR 798.22
Gastrointestinal Tumor Research and Treatment2021-202554FR 397.88
Lung Cancer Treatments and Mutations2021-2025212FR 998.57
Vascular Tumors and Angiosarcomas2021-202523FR 496.49
Genetic factors in colorectal cancer2021-2025183FR 995.86
CAR-T cell therapy research2021-2025465FR 2597.15
Lymphoma Diagnosis and Treatment2021-2025401FR 3096.41
Immune Cell Function and Interaction2021-2025668FR 2393.13
Neurofibromatosis and Schwannoma Cases2021-202594FR 893.38
Colorectal Cancer Treatments and Studies2021-2025387FR 2595.26
Immunotherapy and Immune Responses2021-2025728FR 2492.42
Lung Cancer Research Studies2021-2025466FR 2394.61
Advanced Breast Cancer Therapies2021-2025292FR 2394.77
Immune cells in cancer2021-2025701FR 890.10
Colorectal and Anal Carcinomas2021-2025459FR 3189.53
Cardiac tumors and thrombi2021-2025211FR 2086.49
Cancer Treatment and Pharmacology2021-2025683FR 4687.80
Cancer, Stress, Anesthesia, and Immune Response2021-2025171FR 882.04
Bone Tumor Diagnosis and Treatments2021-2025455FR 2383.19
Cancer-related Molecular Pathways2021-2025567FR 1679.13
Cancer Diagnosis and Treatment2021-2025819FR 3275.46
Musculoskeletal synovial abnormalities and treatments2021-2025325FR 1374.59
Soft tissue tumor case studies2021-2025240FR 2474.29
Melanoma and MAPK Pathways2021-2025920FR 3968.00
Fibroblast Growth Factor Research2021-2025602FR 1865.32
IgG4-Related and Inflammatory Diseases2021-2025413FR 1360.74
Signaling Pathways in Disease2021-2025878FR 1548.01
Mechanisms of cancer metastasis2021-2025103FR 1043.49